Weird and wonderful case studies: Real-world solutions for unexpected bioanalytical challenges
Are you facing unsolvable bioanalytical issues with your existing provider that is impacting your nonclinical or clinical PK/PD study setup? Is there a lack of communication and support with your current CRO?
Weird happens. More often than you expect. Rescue studies are a particular point of strength at Agilex Biolabs, where the bioanalytical experts are driven to solve challenges presented by what we call “the weird and wonderful.”
Sometimes studies go awry, but through shared experience, you can avoid suffering the same pitfalls that others have already experienced. Pharmacokinetic (PK) and Pharmacodynamic (PD) data are critical to non-clinical and clinical safety studies, dose escalation, and decision-making. Delays in assay setup and ongoing bioanalytical challenges during the study can severely impact drug development timelines. When a study needs rescuing, it is critical to choose the appropriate intervention that will get your assay back on track. Having a partner that understands how to troubleshoot bioanalysis issues is critical for success.
What will you learn?
- How to select the right partner for your bioanalysis.
- How to salvage the problematic study – understanding the challenges and applying customized solutions.
- Success stories from a China-based clinical-stage biotech developing first-in-class and best-in-class multi-specific biotherapeutics as well as a small Australian-based first-in-class clinical-stage biotech.
- The benefits of working with an Australian bioanalytical lab.
Who should attend?
Bioanalytical, Biomarker, DMPK scientists, Clinical Operations and sponsors who are struggling with getting their assays setup, working with a tricky compound or who are experiencing communication issues with their current lab which is impacting their study, assay development or clinical timelines.
